Back to Search
Start Over
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B‐related compensated cirrhosis.
- Source :
-
Alimentary Pharmacology & Therapeutics . May2021, Vol. 53 Issue 9, p1040-1041. 2p. - Publication Year :
- 2021
-
Abstract
- LINKED CONTENT This article is linked to Hu et al and Yueh‐Hsia Chiu et al papers. To view these articles, visit https://doi.org/10.1111/apt.16116 and https://doi.org/10.1111/apt.16339 [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 02692813
- Volume :
- 53
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Alimentary Pharmacology & Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 149707060
- Full Text :
- https://doi.org/10.1111/apt.16273